We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Excess MicroRNA from Chromosome 21 Causes Down Syndrome Mental Impairment

By LabMedica International staff writers
Posted on 10 Apr 2013
Some of the neurological impairments typical of Down syndrome (DS) are caused by abnormally high levels of a microRNA (miRNA) that inhibits the manufacture of the protein SNX27 (sorting nexin 27).

DS, also known as trisomy 21, is a chromosomal condition caused by the presence of all or part of a third copy of chromosome 21. More...
It is the most common chromosome abnormality in humans and is typically associated with a delay in cognitive ability and physical growth and a particular set of facial characteristics.

SNX27 is a member of the sorting nexin family, a diverse group of cytoplasmic and membrane-associated proteins involved in endocytosis of plasma membrane receptors and protein trafficking through these compartments. All members of this protein family contain a phosphoinositide binding domain (PX domain). Mice that lack both genes for production of SNX27 have severe neuronal deficits in the hippocampus and cortex while mice with only one SBX27 gene have grossly normal neuroanatomy but have defects in synaptic function, learning, and memory.

Investigators at the Sanford-Burnham Medical Research Institute (La Jolla, CA, USA) analyzed brain tissue from subjects with DS and confirmed that they contained significantly lower levels of SNX27 than was found in normal individuals.

Studies carried out on a DS mouse model revealed that the activity of the SNX27 gene was being regulated by the microRNA miR-155, which is produced on chromosome 21. By having an extra copy of this chromosome an individual with DS generates excess miR-155, which results in abnormally low levels of SNX27 and mental defects.

Additional results published in the March 24, 2013, online edition of the journal Nature Medicine showed that a viral vector containing additional genes for SNX27 production could be inserted into the brains of the DS mice, and that return of SNX27 levels to normal corrected the animals' synaptic and cognitive deficits.

“In the brain, SNX27 keeps certain receptors on the cell surface - receptors that are necessary for neurons to fire properly,” said senior author Dr. Huaxi Xu, professor of neuroscience at the Sanford-Burnham Medical Research Institute. “So, in Down syndrome, we believe lack of SNX27 is at least partly to blame for developmental and cognitive defects.”

Related Links:

Sanford-Burnham Medical Research



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.